These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7004666)

  • 1. Diagnosis of self-induced hyperinsulinism in an insulin-dependent diabetic patient by radioimmunoassay of free C-peptide.
    Meistas MT; Kumar MS; Schumacher OP
    Clin Chem; 1981 Jan; 27(1):184-6. PubMed ID: 7004666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of serum C-peptide immunoreactivity by radioimmunoassay in insulin-dependent diabetics.
    Kumar MS; Schumacher OP; Deodhar SD
    Am J Clin Pathol; 1980 Jul; 74(1):78-82. PubMed ID: 6994486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma C-peptide and diagnosis of factitious hyperinsulinism. Study of an insulin-dependent diabetic patient with "spontaneous" hypoglycemia.
    Couropmitree C; Freinkel N; Nagel TC; Horwitz DL; Rubenstein AH; Metzger B; Rubenstein AH; Hahnel R
    Ann Intern Med; 1975 Feb; 82(2):201-4. PubMed ID: 1115442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factitious hypoglycemia. Diagnosis by measurement of serum C-peptide immunoreactivity and insulin-binding antibodies.
    Scarlett JA; Mako ME; Rubenstein AH; Blix PM; Goldman J; Horwitz DL; Tager H; Jaspan JB; Stjernholm MR; Olefsky JM
    N Engl J Med; 1977 Nov; 297(19):1029-32. PubMed ID: 198659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The validity of C-peptide measurement in the diagnosis of factitious hypoglycemia.
    Dimitriadis G; Raptis S; Zoupas C; Schizas N
    Acta Diabetol Lat; 1980; 17(1):67-71. PubMed ID: 6998244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of free and total insulin and C-peptide in insulin-treated diabetics.
    Kuzuya H; Blix PM; Horwitz DL; Steiner DF; Rubenstein AH
    Diabetes; 1977 Jan; 26(1):22-9. PubMed ID: 830562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Factitious hypoglycaemia in an insulin-dependent diabetic: the value of the estimation of immunoreactive C peptide and insulin blood levels (author's transl)].
    Boyer J; Rohmer V; Davert A; Joubaud F
    Nouv Presse Med; 1979 Jul 14-28; 8(32):2627. PubMed ID: 493062
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin, C-peptide, and proinsulin in nondiabetics and insulin-treated diabetics. Characterization of the proinsulin in insulin-treated diabetics.
    Heding LG
    Diabetes; 1978; 27 Suppl 1():178-83. PubMed ID: 631439
    [No Abstract]   [Full Text] [Related]  

  • 9. Factitious hyperinsulinemic hypoglycemia: confirmation of the diagnosis by a species-specific insulin radioimmunoassay.
    Walfish PG; Feig DS; Bauman WA
    J Endocrinol Invest; 1987 Dec; 10(6):601-4. PubMed ID: 3326893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of plasmatic C-peptide and its clinical uses].
    Cautela G; Barbero PL; Gamba S; Regis G; Bruni B
    Ann Osp Maria Vittoria Torino; 1978; 21(7-12):203-37. PubMed ID: 399164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperinsulinemic hypoglycemia. Differential diagnosis by determination of the species of circulating insulin.
    Bauman WA; Yalow RS
    JAMA; 1984 Nov; 252(19):2730-4. PubMed ID: 6387203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism.
    Vezzosi D; Bennet A; Fauvel J; Caron P
    Eur J Endocrinol; 2007 Jul; 157(1):75-83. PubMed ID: 17609405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased C-Peptide Immunoreactivity in Insulin Autoimmune Syndrome (Hirata Disease) Due to High Molecular Weight Proinsulin.
    Kay RG; Barker P; Burling K; Cohen M; Halsall D; Reimann F; Gribble FM; Semple RK; Church D
    Clin Chem; 2021 Jun; 67(6):854-862. PubMed ID: 34051096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis of insulinomas. Determination of insulin, C-peptide and proinsulin in blood to differentiate between endogenous and exogenous hyperinsulinism].
    Hanssen KF; Torjesen PA; Heding LG
    Tidsskr Nor Laegeforen; 1981 Dec; 101(34-36):1957-60. PubMed ID: 6280336
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of polyethylene glycol (PEG) extraction on the C-peptide determination in sera from insulin-dependent diabetic patients with circulating insulin antibodies.
    Besch W; Keilacker H; Kohnert KD; Ziegler M
    Exp Clin Endocrinol; 1990 Feb; 95(1):119-22. PubMed ID: 2185936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal and glucagon-stimulated plasma C-peptide concentrations in healthy dogs, dogs with diabetes mellitus, and dogs with hyperadrenocorticism.
    Montgomery TM; Nelson RW; Feldman EC; Robertson K; Polonsky KS
    J Vet Intern Med; 1996; 10(3):116-22. PubMed ID: 8743209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of plasma C-peptide analysis and the analytical method in the diagnosis of diabetes related diseases].
    Matsuda A
    Nihon Rinsho; 1990 Dec; 48 Suppl():284-92. PubMed ID: 2086901
    [No Abstract]   [Full Text] [Related]  

  • 18. Circulating serum C-peptide. A brief review of diagnostic implications.
    Horwitz DL; Kuzuya H; Rubenstein AH
    N Engl J Med; 1976 Jul; 295(4):207-9. PubMed ID: 179006
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypoglycemia in a diabetes nurse care coordinator.
    Bauman WA; Merkle LN; Rachman RA; Mitsuto SM
    Diabetes Care; 1984; 7(1):88-91. PubMed ID: 6368155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Beta cell function in insulin-treated diabetes mellitus determined by C-peptide measurement].
    Faber OK
    Ugeskr Laeger; 1980 Jan; 142(4):215-21. PubMed ID: 6986696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.